Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Target Oncol
; 17(3): 355-368, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35699834
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Triple Negative Breast Neoplasms
Type of study:
Diagnostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Target Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Singapore